Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti-PD-1 Antibody.

Mol Cancer Ther · 2023 · PMC10068443 · PMID 36696578

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In addition, the activated GzmB + CD8 + T-cell population showed an increasing trend and the activated GzmB + NK-cell population was significantly increased by eribulin-LF monotherapy.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.